Ideally, our findings should be confirmed in a more relevant model, such as a xenograft model in ovariectomized female mice, preferably using tumor cells that express higher amounts of both ER and HER2 (HER2+/ER+), such as BT474 breast cancer cells. The gene discussed is ERBB2; the disease is breast carcinoma.